Loading...
Docoh

Statera BioPharma (STAB)

Employees
Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

Statera Biopharma, Inc. (the “Company”) held its Annual Meeting of Stockholders virtually on November 9, 2021 (the “2021 Annual Meeting”). The results of matters submitted to a stockholder vote at the 2021 Annual Meeting are as follows:

Proposal No. 1: Election of Directors. Five nominees were elected to serve on the Company’s board of directors until the next annual meeting of stockholders and until their successors are elected and qualified with the votes set forth below:

NomineeForWithheldBroker Non-Votes
Michael K. Handley7,922,5656,546,5974,264,455
Steve Keith Barbarick7,661,2866,807,8764,264,455
Taunia Markvicka5,898,1558,571,0074,264,455
Randy S. Saluck7,038,2547,430,9084,264,455
Lea Verny14,359,917109,2454,264,455


Proposal No. 2: Ratification of Turner, Stone & Company, LLP as the independent registered public accounting firm for fiscal year ending December 31, 2021. The selection of Turner, Stone & Company, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified with the votes set forth below:

ForAgainstAbstain
17,815,413899,52418,680


Proposal No. 3: Approval of an amendment to the Company’s Equity Incentive Plan. The proposal to amend the Company’s Equity Incentive Plan to increase the number of shares of the Company’s common stock available for awards thereunder by 3,000,000 did not receive the required approval. The results of the vote on Proposal No. 3 are set forth below:

ForAgainstAbstainBroker Non-Vote
7,124,1887,279,44365,5314,264,455